Introduction to component-resolved diagnostics in allergy
About this session
Component-resolved diagnostics (CRD) enhance traditional allergy testing by pinpointing the specific allergenic proteins involved in sensitization, enabling a more precise allergy assessment. This session introduces the principles of CRD and explains how it improves allergy diagnosis, risk assessment, and patient management.
Simon Blank
Dr. Simon Blank leads the Molecular & Translational Allergology group at the Center of Allergy and Environment (ZAUM), a collaboration between the Technical University of Munich and Helmholtz Zentrum München. His research focuses on allergen-specific immunotherapy, immune tolerance, and component-resolved diagnostics, particularly in Hymenoptera venom allergy.
He earned his doctorate in 2009, conducted postdoctoral research at the University of Hamburg, and joined Helmholtz Munich in 2013. He obtained his habilitation at TUM in 2016 and became associate professor in 2023. Dr. Blank has pioneered the use of marker allergens for improved allergy diagnostics. His research on antigen 5 allergens and venom-component IgE measurement has significantly advanced clinical allergy management. His work continues to shape novel immunomodulatory strategies for precision medicine in allergic diseases.
Related sessions
Peanut allergies: treatment pathways and options
Peanut components in practice: diagnosing peanut allergy
From dust to pollen: exposure to the most common airborne allergens
Climate change and the impact on pollen allergies
Singleplex allergy diagnostic assays: Are they comparable?
AllergoOncology
